SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Income Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Total Expenditure | ₹395 Cr | ₹478 Cr | ₹453 Cr | ₹453 Cr |
What is the latest Total Expenditure of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹395 Cr |
| Mar2025 | ₹478 Cr |
| Mar2024 | ₹453 Cr |
| Mar2023 | ₹453 Cr |
How is Total Expenditure of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹395 Cr | -17.32 | |
| Mar2025 | ₹478 Cr | 5.48 | |
| Mar2024 | ₹453 Cr | 0.00 | |
| Mar2023 | ₹453 Cr | - | |
Compare Total Expenditure of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹5,740.4 Cr | -0.8% | -15.3% | 39.7% | Stock Analytics | |
| PRIME FOCUS | ₹22,424.8 Cr | 5% | -9.3% | 64.1% | Stock Analytics | |
| SAGILITY | ₹19,661.6 Cr | -5.6% | -1.9% | -6% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹17,180.5 Cr | 3.2% | 22.7% | 20% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,251.7 Cr | 11.9% | 9.3% | -39.7% | Stock Analytics | |
| INDEGENE | ₹14,164.4 Cr | -2.3% | -2.8% | 9.9% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -0.8% |
-15.3% |
39.7% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses